We’ve recently updated our valuation analysis.

Calix Valuation

Is CXL undervalued compared to its fair value, analyst forecasts and its price relative to the market?

[object Object] Score

0/6

Valuation Score 0/6

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • Analyst Forecast

Key Valuation Metric

Which metric is best to use when looking at relative valuation for CXL?

Other financial metrics that can be useful for relative valuation.

CXL key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue48.2x
Enterprise Value/EBITDA-68.7x
PEG Ration/a

Price to Sales Ratio vs Peers

How does CXL's PS Ratio compare to its peers?

The above table shows the PS ratio for CXL vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPSEstimated GrowthMarket Cap
Peer Average1.3x
ORI Orica
0.9x3.5%AU$6.6b
SES SECOS Group
2x21.5%AU$61.6m
SDV SciDev
1x38.1%AU$55.0m
CG1 Carbonxt Group
1.3xn/aAU$23.7m
CXL Calix
49.4x29.7%AU$911.6m

Price-To-Sales vs Peers: CXL is expensive based on its Price-To-Sales Ratio (49.4x) compared to the peer average (1.3x).


Price to Earnings Ratio vs Industry

How does CXL's PE Ratio compare vs other companies in the AU Chemicals Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a7.0%
n/an/an/a

Price-To-Sales vs Industry: CXL is expensive based on its Price-To-Sales Ratio (49.4x) compared to the Australian Chemicals industry average (6.3x)


Price to Sales Ratio vs Fair Ratio

What is CXL's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

CXL PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio49.4x
Fair PS Ratio2.9x

Price-To-Sales vs Fair Ratio: CXL is expensive based on its Price-To-Sales Ratio (49.4x) compared to the estimated Fair Price-To-Sales Ratio (2.9x).


Share Price vs Fair Value

What is the Fair Price of CXL when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate CXL's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate CXL's fair value for valuation analysis.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst CXL forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentAU$5.06
AU$8.25
+63.0%
27.3%AU$10.50AU$6.00n/a2
Nov ’23AU$4.30
AU$8.00
+86.0%
25.0%AU$10.00AU$6.00n/a2
Oct ’23AU$5.78
AU$9.25
+60.1%
8.1%AU$10.00AU$8.50n/a2
Sep ’23AU$6.68
AU$9.25
+38.5%
8.1%AU$10.00AU$8.50n/a2
Aug ’23AU$6.25
AU$9.43
+50.8%
12.5%AU$10.60AU$8.25n/a2
Jul ’23AU$5.92
AU$9.43
+59.2%
12.5%AU$10.60AU$8.25n/a2
Jun ’23AU$7.92
AU$9.35
+18.1%
10.3%AU$10.60AU$8.25n/a3
May ’23AU$8.80
AU$8.78
-0.3%
20.8%AU$10.60AU$6.95n/a2
Apr ’23AU$7.65
AU$7.07
-7.6%
8.5%AU$7.85AU$6.40n/a3
Mar ’23AU$5.99
AU$6.92
+15.5%
9.6%AU$7.85AU$6.40n/a3
Feb ’23AU$5.14
AU$6.92
+34.6%
9.6%AU$7.85AU$6.40n/a3
Jan ’23AU$6.65
AU$6.92
+4.0%
9.6%AU$7.85AU$6.40n/a3
Dec ’22AU$6.67
AU$6.92
+3.7%
9.6%AU$7.85AU$6.40AU$5.153
Nov ’22AU$5.47
AU$6.92
+26.4%
9.6%AU$7.85AU$6.40AU$4.303
Oct ’22AU$5.00
AU$6.92
+38.3%
9.6%AU$7.85AU$6.40AU$5.783
Sep ’22AU$4.11
AU$3.48
-15.3%
12.4%AU$4.00AU$2.94AU$6.683
Aug ’22AU$2.78
AU$3.48
+25.2%
12.4%AU$4.00AU$2.94AU$6.253
Jul ’22AU$2.64
AU$2.96
+12.2%
0.9%AU$3.00AU$2.94AU$5.923
Jun ’22AU$2.82
AU$2.96
+5.1%
0.9%AU$3.00AU$2.94AU$7.923
May ’22AU$2.68
AU$2.85
+6.2%
6.2%AU$3.00AU$2.60AU$8.803
Apr ’22AU$2.28
AU$2.85
+24.9%
6.2%AU$3.00AU$2.60AU$7.653
Mar ’22AU$2.22
AU$1.67
-24.8%
35.2%AU$2.50AU$1.20AU$5.993
Feb ’22AU$1.42
AU$1.40
-1.2%
15.3%AU$1.70AU$1.20AU$5.143
Jan ’22AU$1.08
AU$1.20
+11.6%
7.5%AU$1.31AU$1.09AU$6.653
Dec ’21AU$1.08
AU$1.20
+11.1%
7.5%AU$1.31AU$1.09AU$6.673

Analyst Forecast: Target price is more than 20% higher than the current share price, but there are not enough analysts covering the stock to determine statistical confidence in agreement.


Discover undervalued companies